Malaria-Induced NLRP12/NLRP3-Dependent Caspase-1 Activation Mediates Inflammation and Hypersensitivity to Bacterial Superinfection

English version České info

Cyclic paroxysm and high fever are hallmarks of malaria and are associated with high levels of pyrogenic cytokines, including IL-1β. In this report, we describe a signature for the expression of inflammasome-related genes and caspase-1 activation in malaria. Indeed, when we infected mice, Plasmodium infection was sufficient to promote MyD88-mediated caspase-1 activation, dependent on IFN-γ-priming and the expression of inflammasome components ASC, P2X7R, NLRP3 and/or NLRP12. Pro-IL-1β expression required a second stimulation with LPS and was also dependent on IFN-γ-priming and functional TNFR1. As a consequence of Plasmodium-induced caspase-1 activation, mice produced extremely high levels of IL-1β upon a second microbial stimulus, and became hypersensitive to septic shock. Therapeutic intervention with IL-1 receptor antagonist prevented bacterial-induced lethality in rodents. Similar to mice, we observed a significantly increased frequency of circulating CD14⁺CD16⁻Caspase-1⁺ and CD14^dimCD16⁺Caspase-1⁺ monocytes in peripheral blood mononuclear cells from febrile malaria patients. These cells readily produced large amounts of IL-1β after stimulation with LPS. Furthermore, we observed the presence of inflammasome complexes in monocytes from malaria patients containing either NLRP3 or NLRP12 pyroptosomes. We conclude that NLRP12/NLRP3-dependent activation of caspase-1 is likely to be a key event in mediating systemic production of IL-1β and hypersensitivity to secondary bacterial infection during malaria.

Vyšlo v časopise: Malaria-Induced NLRP12/NLRP3-Dependent Caspase-1 Activation Mediates Inflammation and Hypersensitivity to Bacterial Superinfection. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003885
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003885

Souhrn

Zdroje

1. MurrayCJ, RosenfeldLC, LimSS, AndrewsKG, ForemanKJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413–431.

2. MuellerI, GalinskiMR, BairdJK, CarltonJM, KocharDK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555–566.

3. MillerLH, AckermanHC, SuXZ, WellemsTE (2013) Malaria biology and disease pathogenesis: insights for new treatments. Nat Med 19: 156–167.

4. ParrocheP, LauwFN, GoutagnyN, LatzE, MonksBG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 104: 1919–1924.

5. SharmaS, DeOliveiraRB, KalantariP, ParrocheP, GoutagnyN, et al. (2011) Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35: 194–207.

6. KrishnegowdaG, HajjarAM, ZhuJ, DouglassEJ, UematsuS, et al. (2005) Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606–8616.

7. O'NeillLA, GolenbockD, BowieAG (2013) The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 13: 453–460.

8. VincentJL, OpalSM, MarshallJC, TraceyKJ (2013) Sepsis definitions: time for change. Lancet 381: 774–775.

9. WereT, DavenportGC, HittnerJB, OumaC, VululeJM, et al. (2011) Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol 49: 671–676.

10. LacerdaMV, FragosoSC, AlecrimMG, AlexandreMA, MagalhaesBM, et al. (2012) Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 55: e67–74.

11. CunningtonAJ, de SouzaJB, WaltherM, RileyEM (2012) Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med 18: 120–127.

12. ScottJA, BerkleyJA, MwangiI, OcholaL, UyogaS, et al. (2011) Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet 378: 1316–1323.

13. SchroderK, TschoppJ (2010) The inflammasomes. Cell 140: 821–832.

14. DavisBK, WenH, TingJP (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707–735.

15. HornungV, BauernfeindF, HalleA, SamstadEO, KonoH, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847–856.

16. KannegantiTD, OzorenN, Body-MalapelM, AmerA, ParkJH, et al. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440: 233–236.

17. BrozP, NewtonK, LamkanfiM, MariathasanS, DixitVM, et al. (2010) Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 207: 1745–1755.

18. WangL, ManjiGA, GrenierJM, Al-GarawiA, MerriamS, et al. (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 277: 29874–29880.

19. WilliamsKL, LichJD, DuncanJA, ReedW, RallabhandiP, et al. (2005) The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem 280: 39914–39924.

20. LichJD, WilliamsKL, MooreCB, ArthurJC, DavisBK, et al. (2007) Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol 178: 1256–1260.

21. JeruI, Le BorgneG, CochetE, HayrapetyanH, DuquesnoyP, et al. (2011) Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum 63: 1459–1464.

22. VladimerGI, WengD, PaquetteSW, VanajaSK, RathinamVA, et al. (2012) The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 37: 96–107.

23. FranklinBS, ParrocheP, AtaideMA, LauwF, RopertC, et al. (2009) Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci U S A 106: 5789–5794.

24. MockenhauptFP, CramerJP, HamannL, StegemannMS, EckertJ, et al. (2006) Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci U S A 103: 177–182.

25. KhorCC, ChapmanSJ, VannbergFO, DunneA, MurphyC, et al. (2007) A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523–528.

26. FranklinBS, IshizakaST, LamphierM, GusovskyF, HansenH, et al. (2011) Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci U S A 108: 3689–3694.

27. GrauGE, FajardoLF, PiguetPF, AlletB, LambertPH, et al. (1987) Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210–1212.

28. KarunaweeraND, CarterR, GrauGE, KwiatkowskiD, Del GiudiceG, et al. (1992) Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol 88: 499–505.

29. BauernfeindFG, HorvathG, StutzA, AlnemriES, MacDonaldK, et al. (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183: 787–791.

30. DinarelloCA, CannonJG, WolffSM, BernheimHA, BeutlerB, et al. (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433–1450.

31. JarvisMF, KhakhBS (2009) ATP-gated P2X cation-channels. Neuropharmacology 56: 208–215.

32. FranchiL, KannegantiTD, DubyakGR, NunezG (2007) Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 282: 18810–18818.

33. PetrilliV, PapinS, DostertC, MayorA, MartinonF, et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583–1589.

34. NeteaMG, Nold-PetryCA, NoldMF, JoostenLA, OpitzB, et al. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324–2335.

35. AnsteyNM, DouglasNM, PoespoprodjoJR, PriceRN (2012) Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 80: 151–201.

36. DinarelloCA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519–550.

37. Wagner-JaureggJ, BruetschWL (1946) The history of the malaria treatment of general paralysis. Am J Psychiatry 102: 577–582.

38. AdachiK, TsutsuiH, KashiwamuraS, SekiE, NakanoH, et al. (2001) Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 167: 5928–5934.

39. TogbeD, SchofieldL, GrauGE, SchnyderB, BoissayV, et al. (2007) Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol 170: 1640–1648.

40. LepeniesB, CramerJP, BurchardGD, WagnerH, KirschningCJ, et al. (2007) Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol

41. CobanC, IshiiKJ, UematsuS, ArisueN, SatoS, et al. (2007) Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol 19: 67–79.

42. WuX, GowdaNM, KumarS, GowdaDC (2010) Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 184: 4338–4348.

43. LeorattiFM, FariasL, AlvesFP, Suarez-MutisMC, CouraJR, et al. (2008) Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis 198: 772–780.

44. Sam-AguduNA, GreeneJA, OpokaRO, KazuraJW, BoivinMJ, et al. (2010) TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg 82: 548–555.

45. McCallMB, NeteaMG, HermsenCC, JansenT, JacobsL, et al. (2007) Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J Immunol 179: 162–171.

46. HartgersFC, ObengBB, VoskampA, LarbiIA, AmoahAS, et al. (2008) Enhanced Toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children. Infect Immun 76: 5149–5157.

47. LeorattiFM, TrevelinSC, CunhaFQ, RochaBC, CostaPA, et al. (2012) Neutrophil paralysis in Plasmodium vivax malaria. PLoS Negl Trop Dis 6: e1710.

48. MagalhaesBM, AlexandreMA, SiqueiraAM, MeloGC, GimaqueJB, et al. (2012) Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients. Am J Trop Med Hyg 87: 1119–1124.

49. JakobsenPH, McKayV, Morris-JonesSD, McGuireW, van HensbroekMB, et al. (1994) Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Infect Immun 62: 4374–4379.

50. ArmahHB, WilsonNO, SarfoBY, PowellMD, BondVC, et al. (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6: 147.

51. KayagakiN, WongMT, StoweIB, RamaniSR, GonzalezLC, et al. (2013) Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4. Science 341: 1246–1249 DOI: 10.1126/science.1240248

52. KayagakiN, WarmingS, LamkanfiM, Vande WalleL, LouieS, et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479: 117–121.

53. KawaiT, AdachiO, OgawaT, TakedaK, AkiraS (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115–122.

54. CowderyJS, ChaceJH, YiAK, KriegAM (1996) Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 156: 4570–4575.

55. KaishoT (2012) Pathogen sensors and chemokine receptors in dendritic cell subsets. Vaccine 30: 7652–7657.

56. GuermonprezP, HelftJ, ClaserC, DeroubaixS, KaranjeH, et al. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 19: 730–738.

57. GuardaG, BraunM, StaehliF, TardivelA, MattmannC, et al. (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213–223.

58. MariathasanS, WeissDS, NewtonK, McBrideJ, O'RourkeK, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228–232.

59. DostertC, GuardaG, RomeroJF, MenuP, GrossO, et al. (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4: e6510.

60. GriffithJW, SunT, McIntoshMT, BucalaR (2009) Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 183: 5208–5220.

61. ShioMT, EisenbarthSC, SavariaM, VinetAF, BellemareMJ, et al. (2009) Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5: e1000559.

62. ReimerT, ShawMH, FranchiL, CobanC, IshiiKJ, et al. (2010) Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol 40: 764–769.

63. JeruI, HentgenV, NormandS, DuquesnoyP, CochetE, et al. (2011) Role of interleukin-1beta in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis Rheum 63: 2142–2148.

64. KordesM, MatuschewskiK, HafallaJC (2011) Caspase-1 activation of interleukin-1beta (IL-1beta) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun 79: 3633–3641.

65. LabbeK, MiuJ, YeretssianG, SerghidesL, TamM, et al. (2010) Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signaling. J Immunol 185: 5495–5502.

66. MastroeniP, Vazquez-TorresA, FangFC, XuY, KhanS, et al. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192: 237–248.

67. MeissnerF, SegerRA, MoshousD, FischerA, ReichenbachJ, et al. (2010) Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116: 1570–1573.

68. van BruggenR, KokerMY, JansenM, van HoudtM, RoosD, et al. (2010) Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 115: 5398–5400.

69. van de VeerdonkFL, SmeekensSP, JoostenLA, KullbergBJ, DinarelloCA, et al. (2010) Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A 107: 3030–3033.

70. MouldsJM, BraiM, CohenJ, CortelazzoA, CucciaM, et al. (1998) Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 15: 291–294.

71. StevensonMM, TamMF, BelosevicM, van der MeidePH, PodobaJE (1990) Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS. Infect Immun 58: 3225–3232.

72. CadmanET, AbdallahAY, VoisineC, SponaasAM, CorranP, et al. (2008) Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect Immun 76: 3924–3931.

73. OmerFM, RileyEM (1998) Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med 188: 39–48.

74. RittirschD, Huber-LangMS, FlierlMA, WardPA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4: 31–36.

75. MartinsFS, DalmassoG, ArantesRM, DoyeA, LemichezE, et al. (2010) Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS One 5: e8925.